Common Stock, Shares, Outstanding of CORCEPT THERAPEUTICS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CORCEPT THERAPEUTICS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CORCEPT THERAPEUTICS INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 105,966,000, a 0.81% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CORCEPT THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 105,966,000 +853,000 +0.81% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 105,113,000 +1,708,000 +1.7% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 103,405,000 -4,430,000 -4.1% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q4 2022 107,835,000 +1,895,000 +1.8% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 105,940,000 -10,795,000 -9.2% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 116,735,000 +2,186,000 +1.9% 31 Dec 2020 10-K 15 Feb 2022 2021 FY
Q4 2019 114,549,000 -482,000 -0.42% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q4 2018 115,031,000 +314,000 +0.27% 31 Dec 2018 10-K 24 Feb 2020 2019 FY
Q4 2017 114,717,000 +2,007,000 +1.8% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 114,082,000 +3,201,000 +2.9% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 113,362,000 +2,881,000 +2.6% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 113,112,000 +3,441,000 +3.1% 31 Mar 2017 10-Q 02 May 2017 2017 Q1
Q4 2016 112,710,000 +3,068,000 +2.8% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 110,881,000 +2,136,000 +2% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 110,481,000 +2,252,000 +2.1% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 109,671,000 +1,950,000 +1.8% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 109,642,000 +8,247,000 +8.1% 31 Dec 2015 10-K 06 Mar 2017 2016 FY
Q3 2015 108,745,000 +7,604,000 +7.5% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 108,229,000 +7,106,000 +7% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 107,721,000 +7,032,000 +7% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 101,395,000 +1,546,000 +1.5% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 101,141,000 +1,327,000 +1.3% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 101,123,000 +1,309,000 +1.3% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 100,689,000 +875,000 +0.88% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 99,849,000 +35,000 +0.04% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q3 2013 99,814,000 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 99,814,000 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 99,814,000 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 99,814,000 +15,583,000 +18% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 84,231,000 +11,827,000 +16% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q4 2010 72,404,000 31 Dec 2010 10-K 13 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.